You are here

HER2+

ImPatient Science

The majority of women today are aware of breast cancer from a fairly young age, and there are countless resources available that provide basic information about the disease, risk factors, and screening; e.g., what to do if you have an abnormal mammogram, or ten things to ask your doctor about your diagnosis. At the other end of the information spectrum, patients and family members/caregivers can become lost and discouraged by the universe of complex scientific data available about breast cancer.

Research Worth Watching: A Breast Cancer Vaccine to Decrease HER2+ Recurrence?

As I’ve mentioned before, immunotherapy has become a hot topic in breast cancer research. It garnered a lot of attention from researchers in April at the American Association for Cancer Research 2014 annual meeting (which I wrote about here). And the same was true for the ASCO 2014 Breast Cancer Symposium, held earlier this month in San Francisco.

Research Worth Watching: New Understanding of Cancer and Which Cells are Important

In this Research Worth Watching section, we talk about recent studies that give us new insight into the science of breast cancer—insight that may ultimately change the way we approach the clinical treatment. Although this new research is unlikely to have an immediate impact on care, it helps us understand what we are seeing in the clinical setting.

Two new papers have been published which are causing many to reevaluate their thinking about cancers and which cells are important. Once again, our previous theories have been stood on their heads!

But first, let’s back up.